{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T19:00:41Z","timestamp":1792522841333,"version":"4.5.0"},"reference-count":45,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2015,12,1]],"date-time":"2015-12-01T00:00:00Z","timestamp":1448928000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Immunology"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1016\/j.clim.2015.09.010","type":"journal-article","created":{"date-parts":[[2015,9,24]],"date-time":"2015-09-24T19:11:18Z","timestamp":1443121878000},"page":"333-338","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["Sildenafil attenuates the fibrotic phenotype of skin fibroblasts in patients with systemic sclerosis"],"prefix":"10.1016","volume":"161","author":[{"given":"Tomoaki","family":"Higuchi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasushi","family":"Kawaguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kae","family":"Takagi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akiko","family":"Tochimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuko","family":"Ota","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuhiro","family":"Katsumata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hisae","family":"Ichida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masanori","family":"Hanaoka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hidenaga","family":"Kawasumi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mari","family":"Tochihara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hisashi","family":"Yamanaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clim.2015.09.010_bb0005","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/j.1346-8138.2009.00738.x","article-title":"Mechanisms of skin fibrosis in systemic sclerosis","volume":"37","author":"Jinnin","year":"2010","journal-title":"J. Dermatol."},{"key":"10.1016\/j.clim.2015.09.010_bb0010","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1056\/NEJMra0806188","article-title":"Mechanisms of disease: scleroderma","volume":"360","author":"Gabrielli","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.clim.2015.09.010_bb0015","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.clim.2013.06.006","article-title":"Aberrant histone modification in peripheral blood B cells from patients with systemic sclerosis","volume":"149","author":"Wang","year":"2013","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.clim.2015.09.010_bb0020","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.clim.2013.07.005","article-title":"T lymphocyte abnormalities in juvenile systemic sclerosis patients","volume":"149","author":"Reiff","year":"2013","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.clim.2015.09.010_bb0025","first-page":"1253","article-title":"Evaluation of functional disability using the health assessment questionnaire in Japanese patients with systemic sclerosis","volume":"30","author":"Kuwana","year":"2003","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.clim.2015.09.010_bb0030","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.amjmed.2004.04.031","article-title":"Mortality in systemic sclerosis: an international meta-analysis of individual patient data","volume":"118","author":"Ioannidis","year":"2005","journal-title":"Am. J. Med."},{"key":"10.1016\/j.clim.2015.09.010_bb0035","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1007\/s10067-004-0970-z","article-title":"Health-related quality of life measured by the Short Form 36 (SF-36) in systemic sclerosis: correlations with indexes of disease activity and severity, disability, and depressive symptoms","volume":"24","author":"Danieli","year":"2005","journal-title":"Clin. Rheumatol."},{"key":"10.1016\/j.clim.2015.09.010_bb0040","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1111\/j.1346-8138.2009.00758.x","article-title":"Future treatments in systemic sclerosis","volume":"37","author":"Asano","year":"2010","journal-title":"J. Dermatol."},{"key":"10.1016\/j.clim.2015.09.010_bb0045","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1038\/nrrheum.2009.26","article-title":"Transforming growth factor beta as a therapeutic target in systemic sclerosis","volume":"5","author":"Varga","year":"2009","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.clim.2015.09.010_bb0050","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1007\/s11926-005-0069-9","article-title":"Scleroderma, fibroblasts, signaling, and excessive extracellular matrix","volume":"7","author":"Ihn","year":"2005","journal-title":"Curr. Rheumatol. Rep."},{"key":"10.1016\/j.clim.2015.09.010_bb0055","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1002\/art.37988","article-title":"Review: evidence that systemic sclerosis is a vascular disease","volume":"65","author":"Matucci-Cerinic","year":"2013","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.clim.2015.09.010_bb0060","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1136\/annrheumdis-2011-200862","article-title":"Stimulation of soluble guanylate cyclase reduces experimental dermal fibrosis","volume":"71","author":"Beyer","year":"2012","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.clim.2015.09.010_bb0065","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1038\/333664a0","article-title":"Vascular endothelial cells synthesize nitric oxide from l-arginine","volume":"333","author":"Palmer","year":"1998","journal-title":"Nature"},{"key":"10.1016\/j.clim.2015.09.010_bb0070","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1253\/circj.CJ-12-0664","article-title":"Cyclic GMP-dependent signaling in cardiac myocytes","volume":"76","author":"Takimoto","year":"2012","journal-title":"Circ. J."},{"issue":"4","key":"10.1016\/j.clim.2015.09.010_bb0075","doi-asserted-by":"crossref","first-page":"61","DOI":"10.2147\/DDDT.S6208","article-title":"Update on the clinical utility of sildenafil in the treatment of pulmonary arterial hypertension","volume":"25","author":"Ramani","year":"2010","journal-title":"Drug Des. Devel. Ther."},{"key":"10.1016\/j.clim.2015.09.010_bb0080","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1056\/NEJM200011023431814","article-title":"Sildenafil in primary pulmonary hypertension","volume":"343","author":"Prasad","year":"2000","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.clim.2015.09.010_bb0085","doi-asserted-by":"crossref","first-page":"2148","DOI":"10.1056\/NEJMoa050010","article-title":"Sildenafil Use in Pulmonary Arterial Hypertension (SUPER) Study Group. Sildenafil citrate therapy for pulmonary arterial hypertension","volume":"353","author":"Gali\u00e8","year":"2005","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.clim.2015.09.010_bb0090","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1038\/nrd4228","article-title":"Advances in targeting cyclic nucleotide phosphodiesterases","volume":"13","author":"Maurice","year":"2014","journal-title":"Nat. Rev. Drug Discov."},{"issue":"Suppl 1","key":"10.1016\/j.clim.2015.09.010_bb0095","doi-asserted-by":"crossref","first-page":"S8","DOI":"10.1038\/sj.ijir.3901207","article-title":"Tissue expression, distribution, and regulation of PDE5","volume":"16","author":"Lin","year":"2004","journal-title":"Int. J. Impot. Res."},{"key":"10.1016\/j.clim.2015.09.010_bb0100","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1007\/s10741-008-9130-x","article-title":"Phosphodiesterase inhibition in heart failure","volume":"14","author":"Movsesian","year":"2009","journal-title":"Heart Fail. Rev."},{"key":"10.1016\/j.clim.2015.09.010_bb0105","doi-asserted-by":"crossref","first-page":"F996","DOI":"10.1152\/ajprenal.00657.2013","article-title":"Increasing cGMP-dependent protein kinase activity attenuates unilateral ureteral obstruction-induced renal fibrosis","volume":"306","author":"Cui","year":"2014","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"10.1016\/j.clim.2015.09.010_bb0110","doi-asserted-by":"crossref","first-page":"38644","DOI":"10.1074\/jbc.M606142200","article-title":"Cyclic GMP-dependent protein kinase I alpha attenuates necrosis and apoptosis following ischemia\/reoxygenation in adult cardiomyocyte","volume":"281","author":"Das","year":"2006","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.clim.2015.09.010_bb0115","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.1003889107","article-title":"Regulation and role of myocyte cyclic GMP-dependent protein kinase-1","volume":"107","author":"Kass","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.clim.2015.09.010_bb0120","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1007\/s00395-010-0098-z","article-title":"Novel insights into the mechanisms mediating the local antihypertrophic effects of cardiac atrial natriuretic peptide: role of cGMP-dependent protein kinase and RGS2","volume":"105","author":"Klaiber","year":"2010","journal-title":"Basic Res. Cardiol."},{"key":"10.1016\/j.clim.2015.09.010_bb0125","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.jss.2006.01.012","article-title":"Negative inotropic effects of C-type natriuretic peptide are attenuated in hypertrophied ventricular myocytes associated with reduced cyclic GMP production","volume":"135","author":"Moalem","year":"2006","journal-title":"J. Surg. Res."},{"key":"10.1016\/j.clim.2015.09.010_bb0130","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1038\/ki.2013.219","article-title":"The cyclic GMP-dependent protein kinase I alpha suppresses kidney fibrosis","volume":"84","author":"Schinner","year":"2013","journal-title":"Kidney Int."},{"key":"10.1016\/j.clim.2015.09.010_bb0135","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0021853","article-title":"Soluble guanylate cyclase stimulation prevents fibrotic tissue remodeling and improves survival in salt-sensitive Dahl rats","volume":"6","author":"Geschka","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.clim.2015.09.010_bb0140","doi-asserted-by":"crossref","first-page":"H2272","DOI":"10.1152\/ajpheart.00654.2010","article-title":"Mitigation of the progression of heart failure with sildenafil involves inhibition of RhoA\/Rho-kinase pathway","volume":"300","author":"Chau","year":"2011","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.clim.2015.09.010_bb0145","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1111\/j.1464-410X.2006.05955.x","article-title":"Effects of long-term vardenafil treatment on the development of fibrotic plaques in a rat model of Peyronie's disease","volume":"97","author":"Ferrini","year":"2006","journal-title":"BJU Int."},{"key":"10.1016\/j.clim.2015.09.010_bb0150","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1002\/art.1780271010","article-title":"Cyclic nucleotides and calcium transport in cultured dermal fibroblasts from progressive systemic sclerosis and rheumatoid arthritis patients","volume":"27","author":"Grozdova","year":"1984","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.clim.2015.09.010_bb0155","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.clim.2013.03.001","article-title":"Ghrelin attenuates collagen production in lesional fibroblasts from patients with systemic sclerosis","volume":"147","author":"Ota","year":"2013","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.clim.2015.09.010_bb0160","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1111\/j.0022-202X.2005.23766.x","article-title":"Increased phosphorylation and activation of mitogen-activated protein kinase p38 in scleroderma fibroblasts","volume":"125","author":"Ihn","year":"2005","journal-title":"J. Investig. Dermatol."},{"key":"10.1016\/j.clim.2015.09.010_bb0165","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1002\/art.23146","article-title":"Heparan sulfate-dependent ERK activation contributes to the overexpression offibrotic proteins and enhanced contraction by scleroderma fibroblasts","volume":"58","author":"Chen","year":"2008","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.clim.2015.09.010_bb0170","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1161\/ATVBAHA.113.300156","article-title":"Smoking and cardiovascular disease mechanism of endothelial dysfunction and early atherogenesis","volume":"34","author":"Messner","year":"2014","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.clim.2015.09.010_bb0175","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1254\/jphs.12R01CR","article-title":"Pathophysiological roles of endothelin receptors in cardiovascular diseases","volume":"119","author":"Ohicita","year":"2012","journal-title":"J. Pharmacol. Sci."},{"key":"10.1016\/j.clim.2015.09.010_bb0180","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1093\/eurheartj\/ehr304","article-title":"Nitric oxide synthases: regulation and function","volume":"33","author":"Forstermann","year":"2012","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.clim.2015.09.010_bb0195","unstructured":"Beyer C, Zenzmaier C, Palumbo-Zerr K, Mancuso R, Distler A, Dees C et al. Stimulation of the soluble guanylate cyclase (sGC) inhibits dermal fibrosis by blocking TGF-beta signaling. Ann. Rheum. Dis. DOI: 10.1136 (E-pub)."},{"key":"10.1016\/j.clim.2015.09.010_bb0200","first-page":"114","article-title":"Cyclic nucleotides and calcium transport in cultured dermal fibroblasts from progressive systemic sclerosis and rheumatoid arthritis patients","volume":"27","author":"KJ","year":"1984","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.clim.2015.09.010_bb0205","first-page":"314","article-title":"Nitric oxide production and inducible nitric oxide synthase expression in systemic sclerosis","volume":"25","author":"Yamamoto","year":"1998","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.clim.2015.09.010_bb0210","first-page":"281","article-title":"Increased serum levels of nitrotyrosine, a marker for peroxynitrite production, in systemic sclerosis","volume":"25","author":"Shimizu","year":"2007","journal-title":"Clin. Exp. Rheumatol."},{"key":"10.1016\/j.clim.2015.09.010_bb0215","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1111\/j.1365-2249.2003.02320.x","article-title":"Serum nitric oxide (NO) levels in systemic sclerosis patients: correction between NO levels and clinical features","volume":"134","author":"Takagi","year":"2003","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.clim.2015.09.010_bb0220","doi-asserted-by":"crossref","first-page":"2320","DOI":"10.3390\/ijms16022320","article-title":"Cyclic nucleotide signaling in kidney fibrosis","volume":"16","author":"Schinner","year":"2015","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.clim.2015.09.010_bb0225","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1684\/ejd.2011.1423","article-title":"N-Terminal pro-brain natriuretic peptide in systemic sclerosis: new insights","volume":"21","author":"Elshamy","year":"2011","journal-title":"Eur. J. Dermatol."},{"key":"10.1016\/j.clim.2015.09.010_bb0230","first-page":"408","article-title":"Regulator of G protein signaling 2 mediates cardiac compensation to pressure overload and antihypertrophic effects of PDE5 inhibition in mice","volume":"119","author":"Takimoto","year":"2009","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.clim.2015.09.010_bb0235","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1124\/jpet.109.154468","article-title":"cGMP-hydrolytic activity and its inhibition by sildenafil in normal and failing human and mouse myocardium","volume":"330","author":"Vandeput","year":"2009","journal-title":"J. Pharmacol. Exp. Ther."}],"container-title":["Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521661615300437?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521661615300437?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,9,8]],"date-time":"2020-09-08T18:28:31Z","timestamp":1599589711000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521661615300437"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,12]]},"references-count":45,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["S1521661615300437"],"URL":"https:\/\/doi.org\/10.1016\/j.clim.2015.09.010","relation":{},"ISSN":["1521-6616"],"issn-type":[{"value":"1521-6616","type":"print"}],"subject":[],"published":{"date-parts":[[2015,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Sildenafil attenuates the fibrotic phenotype of skin fibroblasts in patients with systemic sclerosis","name":"articletitle","label":"Article Title"},{"value":"Clinical Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clim.2015.09.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}